NDRAW
Income statement / Annual
Last year (2024), ENDRA Life Sciences Inc. Warrants's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, ENDRA Life Sciences Inc. Warrants's net income was -$11.51 M.
See ENDRA Life Sciences Inc. Warrants,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2024 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$6.17 K |
$351.62 K |
$515.58 K |
$1.41 M |
$559.36 K |
| Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$172.78 K
|
$235.88 K
|
$666.23 K
|
$259.15 K
|
| Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$6.17 K
|
$178.84 K
|
$279.70 K
|
$743.83 K
|
$300.21 K
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
1
|
0.51
|
0.54
|
0.53
|
0.54
|
| Research and Development Expenses |
$3.19 M
|
$5.48 M
|
$5.92 M
|
$6.58 M
|
$4.72 M
|
$1.93 M
|
$495.38 K
|
$1.04 M
|
$873.17 K
|
| General & Administrative Expenses |
$7.06 M
|
$4.94 M
|
$4.42 M
|
$3.44 M
|
$3.49 M
|
$2.63 M
|
$1.54 M
|
$1.22 M
|
$896.93 K
|
| Selling & Marketing Expenses |
$571.04 K
|
$1.08 M
|
$581.89 K
|
$412.43 K
|
$262.64 K
|
$122.60 K
|
$34.13 K
|
$50.64 K
|
$56.30 K
|
| Selling, General & Administrative Expenses |
$7.63 M
|
$6.02 M
|
$5.00 M
|
$3.86 M
|
$3.75 M
|
$2.75 M
|
$1.58 M
|
$1.27 M
|
$953.22 K
|
| Other Expenses |
$0.00
|
$0.00
|
$581.89 K
|
$412.43 K
|
$550.18 K
|
$122.60 K
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$10.82 M
|
$11.50 M
|
$11.50 M
|
$10.84 M
|
$9.03 M
|
$4.80 M
|
$2.07 M
|
$2.31 M
|
$1.83 M
|
| Cost And Expenses |
$0.00
|
$11.50 M
|
$11.50 M
|
$10.84 M
|
$9.03 M
|
$4.98 M
|
$2.31 M
|
$2.98 M
|
$2.09 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$0.00
|
$0.00
|
$232.43 K
|
$2.36 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$224.42 K
|
$99.34 K
|
$2.47 M
|
$797.56 K
|
$772.95 K
|
$64.94 K
|
$72.23 K
|
$37.24 K
|
| EBITDA |
$0.00 |
-$11.01 M |
-$11.39 M |
-$8.48 M |
-$9.00 M |
-$4.60 M |
-$2.71 M |
-$2.21 M |
-$2.14 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
-1457.52
|
-13.09
|
-5.26
|
-1.57
|
-3.83
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
-1460.8
|
-13.16
|
-3.48
|
-1.11
|
-2.73
|
| Total Other Income/Expenses Net |
$0.00
|
$0.00
|
-$223.58 K
|
-$2.46 M
|
-$777.25 K
|
-$750.90 K
|
-$983.61 K
|
-$710.63 K
|
-$654.70 K
|
| Income Before Tax |
-$11.51 M
|
-$11.23 M
|
-$11.73 M
|
-$13.31 M
|
-$9.80 M
|
-$5.38 M
|
-$2.78 M
|
-$2.28 M
|
-$2.18 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
-1586.7
|
-15.29
|
-5.38
|
-1.62
|
-3.9
|
| Income Tax Expense |
$0.00
|
$121.07 K
|
$0.00
|
-$106.90 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$11.51 M
|
-$11.35 M
|
-$11.73 M
|
-$17.53 M
|
-$9.80 M
|
-$5.38 M
|
-$2.78 M
|
-$2.28 M
|
-$2.18 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
-1586.7
|
-15.29
|
-5.38
|
-1.62
|
-3.9
|
| EPS |
-56.94 |
-0.82 |
-0.85 |
-2.34 |
-2.17 |
-1.95 |
-3.84 |
-3.15 |
-0.79 |
| EPS Diluted |
-56.94 |
-0.82 |
-0.85 |
-2.34 |
-2.17 |
-1.95 |
-3.84 |
-3.15 |
-0.79 |
| Weighted Average Shares Out |
$202.11 K
|
$13.80 M
|
$13.80 M
|
$7.50 M
|
$4.50 M
|
$2.76 M
|
$723.34 K
|
$723.34 K
|
$2.76 M
|
| Weighted Average Shares Out Diluted |
$202.11 K
|
$13.80 M
|
$13.80 M
|
$7.50 M
|
$4.50 M
|
$2.76 M
|
$723.34 K
|
$723.34 K
|
$2.76 M
|
| Link |
|
|
|
|
|
|
|
|
|
